RECOVERY Collaborative Group. 2022, 'Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY) : a randomised, controlled, open-label, platform trial', The Lancet, 399(10325), pp. 665-676. https://doi.org/10.1016/S0140-6736(22)00163-5